Vertex Pharmaceuticals (VRTX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Vertex Pharmaceuticals (VRTX)

An SI Board Since August 1996

Posts	SubjectMarks	Bans	Symbol
1169	64	0	VRTX

Emcee: David Lieberman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
994	Thanks for nudging me to stay in, Dew. I even added at 24.91. Hope boceprevir do	tom pope	-	4/25/2008
993	<i>The market must think there's a fishhook in there somewhere, especi	DewDiligence_on_SI	-	4/24/2008
992	Thanks. The market must think there's a fishhook in there somewhere, especia	tom pope	-	4/24/2008
991	VRTX’s EASL PR on the ‘107’ study with annotations: siliconinvestor.com	DewDiligence_on_SI	-	4/24/2008
990	This is worth a pretty good haircut - but the stock had admittedly had quite a r	tom pope	-	4/23/2008
989	<i>Some interesting history of the CF compounds</i> BusinessWeek -	tnsaf	-	4/3/2008
988	<i>>Indirectly, I think that the activity in patients from the rollover	DewDiligence_on_SI	-	3/31/2008
987	Indirectly, I think that the activity in patients from the rollover study should	idos	-	3/31/2008
986	(My bad: EASL abstract has nothing to do with PROVE-3) VRTX +28% on Telaprevir	DewDiligence_on_SI	-	3/31/2008
985	Vertex Lifted by Hepatitis C Drug Data Adam Feuerstein Schering-Plough(SGP - Cra	tnsaf	-	3/31/2008
984	Late-breaking abstract for EASL appears to be about data from PROVE-3: biz.yaho	DewDiligence_on_SI	-	3/31/2008
983	Vertex Announces Positive Results for VX-770, an Oral Investigational Agent That	tnsaf	-	3/27/2008
982	Well------ Vertex also failed to state the side effects associated with VX950 i	Fishfinder	-	3/14/2008
981	As Dew points out, the protocols for the two trials were different. I'm sur	tuck	-	3/13/2008
980	Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against V	LJM	-	3/13/2008
979	Yes—good book.	DewDiligence_on_SI	-	2/11/2008
978	Reminds me. You must have read The Billion Dollar Molecule? If not I think you	keokalani'nui	-	2/11/2008
977	Telaprevir had better be a mega-blockbuster because VRTX will have lost more mon	DewDiligence_on_SI	-	2/11/2008
976	>>4:06PM Vertex Pharm beats by $0.10, misses on revs; guides FY08 revs bel	tuck	-	2/11/2008
975	<i>If you can't believe news stories, what can you believe?</i>	tnsaf	-	1/24/2008
974	Vertex Vexed by FDA Deal By Adam Feuerstein Senior Writer 1/23/2008 12:49 PM E	Doc Bones	-	1/24/2008
973	Bearish VRTX article in ft.com: siliconinvestor.com	DewDiligence_on_SI	-	1/14/2008
972	Amen!	SeachRE	-	1/10/2008
971	Good move by VRTX: They sent new hire, Kurt Graves, to speak at JPM instead of t	DewDiligence_on_SI	-	1/8/2008
970	Vertex Pharma Raised To Buy From Neutral By Goldman >VRTX 7:01 AM ET - Dow J	Susan Saline	-	11/8/2007

Go to reply# or date (mm/dd/yy):